Julphar's Q3 Attributable Profit, Revenue Jump

MT Newswires · 3d ago
06:45 AM EST, 11/12/2026 (MT Newswires) -- Gulf Pharmaceutical Industries (ADX:JULPHAR), d/b/a Julphar, logged 32.9 million Emirati dirhams in profit attributable to equity holders of the parent for the third quarter, compared with 6.3 million dirhams a year ago. EPS moved to 0.0285 dirham from 0.0055 dirham year over year, a Thursday filing showed. For the three months ended Sept. 30, revenue from contracts with customers was 332.3 million dirhams versus 250 million dirhams previously, the United Arab Emirates-listed pharmaceutical manufacturer added.